Jubilant Biosys Limited, a active public limited company, was established on 10 February 1998 in Noida, Uttar Pradesh, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24110UP1998PLC029591. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹328.00 Cr and a paid-up capital of ₹303.70 Cr.
Formerly known as Jubilant Biosys Private Limited. It upholds a compliant status. Its leadership includes Prasant Kumar Deb (Whole-Time Director), Gayatri Taragi (Director), Giuliano Perfetti (Managing Director). Past directors included Rajesh Kumar Srivastava, Arvind Chokhany, Hari Shanker Bhartia. It holds ₹570.00 Cr open charges and ₹14.30 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at 1A, Sector 16 A, Noida, Uttar Pradesh, 201301.
U24110UP1998PLC029591
029591
10 February 1998
₹328.00 Cr
₹303.70 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Jubilant Biosys Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasant Kumar Deb | Whole-Time Director | 03 Jun 2021 | Current |
| Gayatri Taragi | Director | 29 Apr 2023 | Current |
| Giuliano Perfetti | Managing Director | 27 Jan 2022 | Current |
| Sreekanth Reddy Rouduri | Whole-Time Director | 13 May 2025 | Current |
| Ramakrishnan Arul | Additional Director | 01 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 01 Nov 2021 | Past |
| Pramod Abcsdd | Director | 06 Mar 2013 | Past |
| Pramod Abcsdd | Director | 28 Mar 2018 | Past |
| Pramod Abcsdd | Director | 17 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 04 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jubilant Biosys Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.55% increase. The company also saw a slight decrease in profitability, with a 7.97% decrease in profit. The company's net worth Soared by an impressive increase of 22.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jubilant Biosys had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,700,000,000.00
₹143,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2025 | Others | ₹70.00 Cr | Open |
| 28 Aug 2025 | Others | ₹50.00 Cr | Open |
| 28 Aug 2025 | Yes Bank Limited | ₹50.00 Cr | Open |
| 06 Jun 2025 | The Hongkong And Shanghai Banking Corporation Limited | ₹150.00 Cr | Open |
| 09 Aug 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹125.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Jubilant Biosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jubilant Biosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Biosys's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ramakrishnan Arul was appointed as a Additional Director was appointed as a Additional Director on 01 Sep 2025 & has been associated with this company since 3 months 1 day . was documented.
A charge with Others amounted to Rs. 70.00 Cr with Charge ID 101158317 was registered on 29 Aug 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101158469 was registered on 28 Aug 2025. was documented.
Progress on A charge with Yes Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101148870 was registered on 28 Aug 2025. was documented.
Jubilant Biosys Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 150.00 Cr registered on 06 Jun 2025 with Charge ID 101114625 was modified on 31 Jul 2025. was recorded as a recent event.
The company, which is a Contract Research Development and Manufacturing Organisation (CRDMO), offers comprehensive drug discovery, development and manufacturing services to global healthcare companies.
/PRNewswire/ -- Jubilant Biosys, a wholly owned subsidiary of Jubilant Life Sciences, announced today that it has recently added advanced Pioneer FE system to....
/PRNewswire/ -- Jubilant Biosys and Collaborative Drug Discovery (CDD) announced today, following an exhaustive evaluation, Jubilant has chosen CDD Vault as....
/PRNewswire/ -- Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd, announced today that it has added advanced Pioneer FE system to its platform of....
When you and your squad tryna find drugs to cure brain problems. Jubilant Biosys, a company from Bengaluru, is helping us out. #BrainPower #CollaborationGoals #SmallButMighty.
The CIN of Jubilant Biosys Limited is U24110UP1998PLC029591.
Jubilant Biosys Limited is headquartered at 1A, Sector 16 A, Noida, Uttar Pradesh, 201301.
Jubilant Biosys Limited was incorporated on 10 February 1998.
The current directors of Jubilant Biosys Limited are
The primary industry of Jubilant Biosys Limited is Professional, Scientific And Technical.
Jubilant Biosys Limited is unlisted.
The authorized capital of Jubilant Biosys Limited is ₹328.00 Cr, and the paid-up capital is ₹303.70 Cr.
The compliance status of Jubilant Biosys Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX